Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 2/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.42 |
| ▸ | GAPDH | P04406 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1015738 | 1.00 | FPR2 (0.56) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL25332329 | 0.86 | FPR2 (0.62) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL17565690 | 0.85 | FPR2 (0.53) | FPR2NFKB1NFKB2RELAGPR84 | |
| SCHEMBL1958482 | 0.85 | FPR2 (0.65) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL1958483 | 0.85 | FPR2 (0.65) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL30140776 | 0.84 | FPR2 (0.44) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL1506635 | 0.81 | FPR2 (0.39) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL21552032 | 0.81 | FPR2 (0.39) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL2494373 | 0.81 | ACHE (0.68) | FPR2NFKB1NFKB2RELAACHE | |
| SCHEMBL2494371 | 0.81 | ACHE (0.68) | FPR2NFKB1NFKB2RELAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115515614-A | Compositions comprising extracts of alpinia and other plants for improving joint health and treating arthritis | 尤尼根公司 | 2022-12-23 | — | — | CN | disclosed |
| EP-4100034-A1 | COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS | Unigen, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20220000964-A1 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | UNIGEN, INC. (US) | 2022-01-06 | — | — | US | disclosed |
| WO-2021159042-A1 | COMPOSITIONS COMPRISING EXTRACTS OF APLINIA AND OTHER PLANTS FOR IMPROVING JOINT HEALTH AND TREATING ARTHRITIS | UNIGEN, INC. (US) | 2021-08-12 | — | — | WO | disclosed |
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | disclosed |
| US-7482479-B2 | Production of cis-pellitorin and use as a flavouring | SYMRISE GMBH & CO., KG (DE) | 2009-01-27 | — | — | US | disclosed |
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | SYMRISE AG (DE) | 2005-10-20 | — | — | US | disclosed |
| EP-1517880-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | Symrise GmbH & Co. KG (DE) | 2005-03-30 | — | — | EP | disclosed |
| WO-2004000787-A2 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE GMBH & CO. KG (DE) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234132-A1 | Production of cis-pellitorin and use as a flavouring | NISCH, CYP8B1, DLAT | FPR2 1699/4885NFKB1 460/4885NFKB2 762/4885 |
| US-20220000964-A1 | Compositions and Methods for Regulating Homeostasis of Chondrocytes, Extracellular Matrix, Articular Cartilage, and Phenotype of Arthritis | COL2A1, COL1A1, CKAP4 | FPR2 4011/4885NFKB1 2329/4885NFKB2 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.